Chemfab Alkalis Limited
NSE:CHEMFAB.NS
1014.65 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,272.968 | 3,311.226 | 2,712.692 | 1,805.823 | 2,041.894 | 1,930.892 | 1,840.255 | 1,404.331 | 1,013.127 | 1,103.908 | 1,126.649 | 1,159.313 | 765.173 | 799.982 | 872.875 | 899.004 |
| Cost of Revenue
| 2,560.475 | 1,744.087 | 1,740.078 | 1,201.254 | 1,120.295 | 969.642 | 919.937 | 739.115 | 491.928 | 627.71 | 619.163 | 547.009 | 375.26 | 439.356 | 468.423 | 439.943 |
| Gross Profit
| 712.493 | 1,567.139 | 972.614 | 604.569 | 921.599 | 961.25 | 920.318 | 665.216 | 521.199 | 476.198 | 507.487 | 612.305 | 389.913 | 360.625 | 404.452 | 459.061 |
| Gross Profit Ratio
| 0.218 | 0.473 | 0.359 | 0.335 | 0.451 | 0.498 | 0.5 | 0.474 | 0.514 | 0.431 | 0.45 | 0.528 | 0.51 | 0.451 | 0.463 | 0.511 |
| Reseach & Development Expenses
| 0 | 6.553 | 4.035 | 6.319 | 6.605 | 6.837 | 5.607 | 6.443 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 235.313 | 35.643 | 24.043 | 25.205 | 19.295 | 18.66 | 19.1 | 26.206 | 19.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.944 | 43.532 | 15.137 | 25.042 | 16.515 | 11.125 | 19.503 | 0.346 | 8.741 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 397.052 | 79.175 | 39.18 | 50.247 | 35.81 | 29.785 | 38.603 | 26.553 | 28.707 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 85.446 | 17.297 | 31.524 | 6.88 | 10.62 | 13.579 | 7.031 | -46.344 | 326.303 | 352.378 | 289.7 | 289.049 | 285.097 | 274.507 | 305.61 | 333.595 |
| Operating Expenses
| 397.052 | 720.655 | 614.757 | 566.029 | 613.248 | 497.666 | 514.195 | 406.76 | 355.01 | 352.378 | 289.7 | 289.049 | 285.097 | 274.507 | 305.61 | 333.595 |
| Operating Income
| 315.441 | 877.085 | 355.888 | 35.139 | 302.332 | 463.584 | 406.123 | 259.131 | 133.728 | 158.619 | 247.523 | 348.302 | 120.201 | 122.281 | 105.56 | 119.648 |
| Operating Income Ratio
| 0.096 | 0.265 | 0.131 | 0.019 | 0.148 | 0.24 | 0.221 | 0.185 | 0.132 | 0.144 | 0.22 | 0.3 | 0.157 | 0.153 | 0.121 | 0.133 |
| Total Other Income Expenses Net
| 76.024 | 17.301 | 35.131 | -14.881 | -35.212 | -178.749 | -8.366 | -103.708 | -32.461 | 34.799 | 29.736 | 25.046 | 13.725 | 36.163 | 6.717 | -5.819 |
| Income Before Tax
| 391.465 | 894.386 | 391.019 | 20.258 | 267.12 | 284.835 | 397.757 | 154.748 | 133.728 | 158.619 | 247.523 | 348.302 | 118.541 | 122.281 | 105.56 | 119.648 |
| Income Before Tax Ratio
| 0.12 | 0.27 | 0.144 | 0.011 | 0.131 | 0.148 | 0.216 | 0.11 | 0.132 | 0.144 | 0.22 | 0.3 | 0.155 | 0.153 | 0.121 | 0.133 |
| Income Tax Expense
| 128.234 | 248.553 | 103.551 | 101.573 | 12.659 | 117.277 | 143.012 | -38.999 | 47.121 | 56.35 | 83.048 | 113.478 | -43.8 | 25.534 | 33.409 | 41.246 |
| Net Income
| 263.231 | 645.833 | 287.468 | -81.315 | 254.461 | 167.558 | 254.745 | 154.748 | 86.606 | 102.27 | 164.475 | 234.824 | 74.742 | 96.747 | 72.151 | 78.402 |
| Net Income Ratio
| 0.08 | 0.195 | 0.106 | -0.045 | 0.125 | 0.087 | 0.138 | 0.11 | 0.085 | 0.093 | 0.146 | 0.203 | 0.098 | 0.121 | 0.083 | 0.087 |
| EPS
| 18.53 | 45.61 | 20.36 | -5.81 | 18.37 | 12.07 | 18.42 | 11.23 | 0.87 | 11.15 | 17.93 | 25.6 | 8.15 | 10.55 | 7.87 | 8.55 |
| EPS Diluted
| 18.34 | 45.14 | 20.2 | -5.77 | 18.27 | 11.96 | 18.16 | 11.08 | 0.87 | 11.15 | 17.93 | 25.6 | 8.15 | 10.55 | 7.87 | 8.55 |
| EBITDA
| 538.949 | 1,097.269 | 628.127 | 244.185 | 580.8 | 621.297 | 523.863 | 349.94 | 293.162 | 261.465 | 279.984 | 390.063 | 172.885 | 169.907 | 183.888 | 220.159 |
| EBITDA Ratio
| 0.165 | 0.331 | 0.232 | 0.135 | 0.284 | 0.322 | 0.285 | 0.249 | 0.289 | 0.237 | 0.249 | 0.336 | 0.226 | 0.212 | 0.211 | 0.245 |